1. RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma
   Yanfang Jiang et al, 2024, Investigational New Drugs CrossRef
2. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding
   Ying Lin et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
3. The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population
   Li Zhang et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
4. Breast cancer genomic analyses reveal genes, mutations, and signaling networks
   Gowrang Kasaba Manjunath et al, 2024, Functional & Integrative Genomics CrossRef
5. Identifying Key Lysosome-Related Genes Associated with Drug-Resistant Breast Cancer Using Computational and Systems Biology Approach
   Aref Shiralipour et al, 2022, Iranian Journal of Pharmaceutical Research CrossRef
6. Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
   Jing Ma et al, 2023, Breast Cancer: Targets and Therapy CrossRef
7. Bisphenol S and Epidermal Growth Factor Receptor Signaling in Human Placental Cytotrophoblasts
   Elvis Ticiani et al, 2021, Environmental Health Perspectives CrossRef